Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Technology in Cancer Research & Treatment|November 1, 2023
Research Progress of Immuno-Inhibitory Receptors in Gynecological Cervical CancerYang Li, Fangrong Shen, Qingqing Tan, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 11, 2024
Current understanding of circular RNAs in preeclampsiaYajun Shi, Fangrong Shen, Xionghui Chen, et al.
American Journal of Translational Research|July 26, 2021
Effect of comprehensive care on the negative emotions and life quality in parturients with postpartum depression and gestational hypertensionYuanzhen Pan, Liping Ni, Suimei Fang, et al.
Glycoconjugate Journal|August 1, 2012
Osteopontin increases the expression of β1, 4-galactosyltransferase-I and promotes adhesion in human RL95-2 cellsFeixin Zhu, Fangrong Shen, Yichao Fan, et al.
Gynecologic and Obstetric Investigation|December 11, 2023
Exploring the Diagnostic Potential of EPB41L3 Methylation in Cervical Cancer and Precancerous Lesions: A Systematic Review and Meta-AnalysisYing Sha, Yunyun Liu, Xiaoxiao Yang, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 14, 2020
Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort studyYi Zhang, Fangrong Shen, Weiwen Yang, et al.
Drug Development Research|June 30, 2021
Overexpression of ARHI increases the sensitivity of cervical cancer cells to paclitaxel through inducing apoptosis and autophagyYang Wang, Fangrong Shen, Jinhua Zhou, et al.
Bioscience Reports|March 20, 2020
Hypoxia-induced up-regulation of miR-27a promotes paclitaxel resistance in ovarian cancerLanlan Feng, Fangrong Shen, Jinhua Zhou, et al.
Current Opinion in Obstetrics & Gynecology|December 16, 2014
New ways to successfully target tumor vasculature in ovarian cancerXiaoyun Yang, Fangrong Shen, Wei Hu, et al.
Oncology Letters|August 30, 2022
tRNA-derived fragment tRF-Glu49 inhibits cell proliferation, migration and invasion in cervical cancer by targeting FGL1Yang Wang, Wenying Xia, Fangrong Shen, et al.
Pageof 5